Fusarium verticillioides fungemia in a liver transplantation patient: successful treatment with voriconazole

被引：19

作者：

Cocchi, Stefania ^{[1
,2
]}

Codeluppi, Mauro ^{[1
,2
]}

Venturelli, Claudia ^{[3
]}

Bedini, Andrea ^{[1
,2
]}

Grottola, Antonella ^{[3
]}

Gennari, William ^{[3
]}

Cavrini, Francesca ^{[4
]}

Di Benedetto, Fabrizio ^{[5
]}

De Ruvo, Nicola ^{[5
]}

Rumpianesi, Fabio ^{[3
]}

Gerunda, Giorgio Enrico ^{[5
]}

Guaraldi, Giovanni ^{[1
,2
]}

机构：

[1] Univ Modena & Reggio Emilia, Azienda Osped Univ Policlin, Clin Infect Dis, Dept Med & Med Special,Microbiol Lab, I-41124 Modena, Italy

[2] Univ Modena & Reggio Emilia, Azienda Osped Univ Policlin, Clin Infect Dis, Dept Med & Med Special,Virol Lab, I-41124 Modena, Italy

[3] Univ Modena & Reggio Emilia, Azienda Osped Univ Policlin, Dept Diagnost & Lab Serv & Legal Med, I-41124 Modena, Italy

[4] Univ Bologna, S Orsola Malpighi Hosp, Dept Hematol & Oncol, Microbiol Unit, Bologna, Italy

[5] Univ Modena & Reggio Emilia, Azienda Osped Univ Policlin, Dept Gen Surg, Liver & Multivisceral Transplant Ctr, I-41124 Modena, Italy

来源：

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2011年 / 71卷 / 04期

关键词：

Liver transplantation; Disseminated Fusarium verticillioides infection; Invasive fusariosis; Systemic fusariosis; Voriconazole; IMMUNOCOMPROMISED PATIENTS; FUNGAL-INFECTIONS; AMPHOTERICIN-B; CANCER CENTER; ASPERGILLUS; IDENTIFICATION; MALIGNANCIES; EXPERIENCE; CRITERIA;

D O I：

10.1016/j.diagmicrobio.2011.08.024

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Fusarium is an opportunistic fungal pathogen which is emerging as a significant cause of morbidity and mortality in immunocompromised hosts. We present a rare case of F. verticillioides fungemia that occurred in a patient who underwent a second orthotopic liver transplantation for chronic rejection and completely responded to treatment with voriconazole. (C) 2011 Elsevier Inc. All rights reserved.

引用

页码：438 / 441

页数：4

共 20 条

[1] Salvage therapy with voriconazole for invasive fungal infections in patients failing or intolerant to standard antifungal therapy [J].